GC Wealth Management RIA’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22M Sell
18,328
-1,509
-8% -$1.54M 1.27% 14
2026
Q1
$18.2M Buy
19,837
+192
+1% +$195K 0.76% 20
2025
Q4
$21.1M Sell
19,645
-6,653
-25% -$6.36M 0.78% 19
2025
Q3
$20.1M Buy
26,298
+14,305
+119% +$10.6M 0.66% 23
2025
Q2
$9.35M Buy
11,993
+8,820
+278% +$6.85M 0.76% 16
2025
Q1
$2.62M Sell
3,173
-71
-2% -$59.1K 0.48% 47
2024
Q4
$2.5M Sell
3,244
-10
-0.3% -$8.28K 0.44% 54
2024
Q3
$2.88M Buy
3,254
+74
+2% +$66.5K 0.5% 40
2024
Q2
$2.88M Sell
3,180
-144
-4% -$115K 0.57% 31
2024
Q1
$2.59M Buy
3,324
+895
+37% +$637K 0.52% 37
2023
Q4
$1.42M Buy
+2,429
New +$1.42M 0.64% 42

Other funds holding LLY

GC Wealth Management RIA's LLY Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Eli Lilly (LLY) stake by 7.6% in Q2 2026, selling an estimated $1.54M and leaving 18,328 shares worth $22M. The position accounts for 1.27% of the portfolio, ranked #14.

GC Wealth Management RIA first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GC Wealth Management RIA held 18,328 shares of Eli Lilly worth $22M as of Q2 2026.
  • GC Wealth Management RIA sold 1,509 Eli Lilly shares in Q2 2026, an estimated $1.54M.
  • Eli Lilly made up 1.27% of GC Wealth Management RIA's portfolio in Q2 2026, its #14 holding.
  • GC Wealth Management RIA first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.